Stock ACLS THER
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar ACLS THER Nasdaq

Equities

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for ACLS THER
16/07 Aclaris Therapeutics Sells Olumiant Royalties, Milestone Payments From Eli Lilly MT
05/07 Aclaris Therapeutics Insider Bought Shares Worth $405,894, According to a Recent SEC Filing MT

Chart calendar ACLS THER

9ad3471ad94.KiIqkJxDC-jQjFq2mRtDCS5uU6MmW2uIQZQylUPs1VY.TRpm5fc7aqOIwB6H7VMgOl4oHpRjMD3QI9ALxjrdsGBicRvTziZ7g6DkCw~95545f68b8f78224e8e2710ab4521662

Upcoming events on ACLS THER

08/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
20/02/2025 Q4 2024 Earnings Release (Projected)
13/05/2025 Q1 2025 Earnings Release (Projected)

Past events on ACLS THER

11/06/2024 08:50 pm Goldman Sachs Global Healthcare Conference
06/06/2024 06:30 pm Annual General Meeting
08/05/2024 02:30 am Q1 2024 Earnings Call
08/05/2024 01:31 am Q1 2024 Earnings Release
27/02/2024 05:30 pm Q4 2023 Earnings Release
13/11/2023 06:30 pm Zunsemetinib Phase IIb Rheumatoid Arthritis Trial Results Call
06/11/2023 05:30 pm Q3 2023 Earnings Release
26/09/2023 08:00 pm Cantor Global Healthcare Conference
07/08/2023 04:30 pm Q2 2023 Earnings Release
15/06/2023 05:10 am Goldman Sachs Global Healthcare Conference
09/06/2023 02:00 am Jefferies Global Healthcare Conference
01/06/2023 06:30 pm Annual General Meeting
08/05/2023 05:30 pm Q1 2023 Earnings Call
08/05/2023 04:30 pm Q1 2023 Earnings Release
30/03/2023 10:30 pm H.C. Wainwright Autoimmune & Inflammatory Disease Conference
23/02/2023 05:30 pm FY 2022 Earnings Release
14/02/2023 07:50 pm SVB Securities Global Biopharma Conference
12/01/2023 03:45 am JP Morgan Healthcare Conference
29/11/2022 08:00 pm Piper Sandler Healthcare Conference
16/11/2022 10:30 pm Jefferies London Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		4,23
12,7
-66.79%		6,48
6,29
2.97%		6,76
7,05
-4.13%		29,8
24,0
24%		31,2
18,3
70.43%
10,6

EBITDA
Million USD		Released
Forecast
Spread 		-86,1
-84,1
-2.37%		0,00
0,00
- 		0,00
0,00
- 		-89,1
-84,1
-5.84%		-96,5
-123
21.74%
-87,4

EBIT
Million USD		Released
Forecast
Spread 		-92,6
-120
22.96%		-50,9
-48,4
-5.08%		-89,7
-90,1
0.38%		-89,9
-91,7
2.05%		-97,4
-119
17.94%
-63,7

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-114
-129
12.29%		-51,3
-48,6
-5.7%		-90,9
-91,1
0.21%		-86,9
-91,0
4.51%		-88,8
-113
21.66%
-58,5

Net income
Million USD		Released
Forecast
Spread 		-161
-131
-23.07%		-51,0
-48,7
-4.83%		-90,9
-91,0
0.2%		-86,9
-90,5
3.94%		-88,5
-112
20.68%
-53,3

EPS
USD		Released
Forecast
Spread 		-3,90
-3,17
-22.9%		-1,20
-1,15
-4.05%		-1,60
-1,61
0.42%		-1,33
-1,46
8.98%		-1,27
-1,60
20.68%
-0,75

Announcement Date25/02/2025/02/2124/02/2223/02/2327/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		1,45
1,67
-12.74%		1,53
1,61
-5.2%		19,0
1,60
1085.34%		7,75
1,99
288.82%		2,53
1,75
44.6%		1,87
1,90
-1.6%		9,28
1,57
489.83%		17,6
5,05
247.87%		2,40
1,93
24.33%
1,82


2,70


3,71


1,94


1,69

EBIT
Million USD		Released
Forecast
Spread 		-18,9
-24,6
23.11%		-21,0
-24,5
14.23%		-20,9
-26,5
21.34%		-29,1
-29,8
2.57%		-29,9
-29,1
-2.8%		-31,8
-31,8
-0.14%		-31,6
-34,3
7.92%		-4,05
-25,2
83.92%		-18,9
-14,3
-32.23%
-16,3


-14,7


-13,7


-18,9


-20,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-18,8
-24,6
23.56%		-20,5
-24,4
15.97%		-20,0
-26,9
25.86%		-27,6
-30,8
10.22%		-28,2
-29,0
2.75%		-29,6
-32,1
7.92%		-29,3
-34,3
14.77%		-1,86
-25,2
92.62%		-16,9
-20,4
16.8%
-14,3


-13,7


-13,6


-23,9


-24,1

Net income
Million USD		Released
Forecast
Spread 		-18,8
-24,8
24.29%		-20,5
-23,8
13.71%		-20,0
-26,3
24.16%		-27,6
-30,5
9.35%		-28,2
-29,2
3.62%		-29,6
-31,7
6.67%		-29,3
-33,9
13.81%		-1,49
-23,6
93.69%		-16,9
-20,3
16.64%
-13,5


-12,0


-10,9


-19,4


-19,7

EPS
USD		Released
Forecast
Spread 		-0,31
-0,40
23.14%		-0,31
-0,36
13.49%		-0,30
-0,40
24.19%		-0,41
-0,46
10.14%		-0,42
-0,44
4.55%		-0,42
-0,45
7.44%		-0,41
-0,48
14.81%		-0,02
-0,33
94.01%		-0,24
-0,27
11.11%
-0,19


-0,17


-0,15


-0,22


-0,22

Announcement Date10/05/2203/08/2208/11/2223/02/2308/05/2307/08/2306/11/2327/02/2407/05/24-----

Upcoming sector events for ACLS THER

22/07/2024 MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release
22/07/2024 04:30 pm IQVIA HOLDINGS INC.: Q2 2024 Earnings Release
24/07/2024 SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release
24/07/2024 ALKERMES PLC: Q2 2024 Earnings Release (Projected)
24/07/2024 ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release
25/07/2024 LONZA GROUP AG: Q2 2024 Earnings Release
25/07/2024 10:30 am BACHEM HOLDING AG: Q2 2024 Earnings Release
26/07/2024 PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
26/07/2024 10:30 am BB BIOTECH AG: Q2 2024 Earnings Release
29/07/2024 CRISPR THERAPEUTICS AG: Q2 2024 Earnings Release (Projected)
More events

Past sector events for ACLS THER

15/07/2024 11:15 am ADDLIFE AB: Q2 2024 Earnings Release
10/07/2024 12:31 pm SUNMAX BIOTECHNOLOGY CO., LTD.: June 2024 Sales and Revenue Release
10/07/2024 11:21 am POLARIS GROUP: June 2024 Sales and Revenue Release
11/06/2024 12:34 pm SUNMAX BIOTECHNOLOGY CO., LTD.: May 2024 Sales and Revenue Release
07/06/2024 12:27 pm POLARIS GROUP: May 2024 Sales and Revenue Release
30/05/2024 01:31 am IMMUNOVANT, INC.: Q4 2024 Earnings Release
23/05/2024 04:30 pm CUREVAC N.V.: Q1 2024 Earnings Release
22/05/2024 10:30 am EVOTEC SE: Q1 2024 Earnings Release
22/05/2024 02:44 am ALVOTECH: Q1 2024 Earnings Release
21/05/2024 04:30 pm EXSCIENTIA PLC: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. ACRS Stock
  4. Stock
  5. Calendar ACLS THER